Home / Inspections / 1027726

FDA Inspection 1027726 — ImprimisRx NJ LLC

ImprimisRx NJ LLC — FEI 3003348498

The FDA completed an inspection of ImprimisRx NJ LLC on July 10, 2017 in Ledgewood, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 10, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ledgewood, NJ (United States)

Facility

Other inspections at this facility

  • 1177284 (OAI Fri Aug 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1087778 (VAI Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945463 (VAI Wed Sep 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886479 (VAI Wed Jul 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 845707 (OAI Mon Aug 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources